等待開盤 07-19 09:30:00 美东时间
0.000
0.00%
Travere Therapeutics (NASDAQ:TVTX) completed its Type C meeting with the U.S. Food and Drug Administration and plans to submit a supplemental New Drug Application seeking traditional approval of FILSP...
02-11 20:51
Thirteen abstracts, including five late-breaking abstracts, underscore Jazz's ongoing commitment to advancing the understanding and treatment of serious sleep disorders Oral presentation of ...
2024-05-30 19:30
As of Dec. 5, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
2023-12-05 22:05
TERN-501 demonstrated dose dependent MRI-PDFF reductions at Week 12 as a once-daily, low dose, and combinable oral therapy TERN-501 (6mg) showed statistically significant mean relative liver fat content reduction
2023-08-09 05:42
DUET Acquisition Corp. (NASDAQ:DUET – Get Rating) saw a significant growth in s...
2023-04-03 05:32
Karpus Management Inc. raised its holdings in shares of DUET Acquisition Corp. ...
2023-03-07 22:14
DUET Acquisition Corp. (NASDAQ:DUET – Get Rating) was the target of a significa...
2023-03-02 05:33
DUET Acquisition Corp. (NASDAQ:DUET – Get Rating) saw a significant growth in s...
2023-02-18 09:22
DUET Acquisition Corp. (NASDAQ:DUET – Get Rating) was the target of a large gro...
2023-01-20 07:31